argenx SE announced that at the Annual General Meeting of shareholders held on May 7, 2024 Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the Board, supporting the Company?s innovation mission across therapeutic areas.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
340.7 EUR | +1.04% | +0.89% | -0.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.82% | 21.96B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors